US FDA External Controls Guidance Does Little To Advance The Cause, Especially In Rare Diseases – Comments

 
• By Sue Sutter
  
Road obstruction
Stakeholders would like the FDA to take a less obstructionist approach to use of externally controlled trials. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Real-World Evidence

More from Clinical Trials